2. READ/LISTEN/TALK to
Not to contradict & Confute.
Nor to believe & take it for granted.
Nor to find & discourse.
But to weigh & consider.
Francis Bacon
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
2
3. Litigant and evidence based world..
Don’t simply knock off the uterus.
Uterus is a marker of FEMINITY.
Make all efforts to save it
Comprehensive evaluation can offer
specific treatment.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
3
4. Perimenopausal bleeding
It is 3-5 years period before menopause
with increase frequent irregular
anovulatory bleeding followed by
episodes of ammenorrhea and
intermittent menopausal symptoms.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
4
5. low resource …
basic investigations for abnormal uterine
bleeding (AUB) –
bearing in mind issues of effectiveness and
cost effectiveness.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
5
6.
Ideally, the evaluation is comprehensive,
considering each of the potential
etiological domains as defined by FIGO
PALM-COEIN system for Causes.
International Journal of Gynecology and Obstetrics
113 (2011) 3–13
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
6
8.
the extent of investigations will be
significantly influenced by the
technologies available and the time allotted
for a consultation.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
8
9.
investigations should be performed only if
they will make a material difference to the
management approaches that can be
offered.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
9
10. AUB
heavy menstrual bleeding (HMB),
intermenstrual bleeding (IMB), and
irregular menstrual bleeding are very
common.
Semin Reprod Med 2011;29(5):383–390
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
10
11. Medications that can be associated
with abnormal uterine bleeding
Anticoagulants
Antidepressants (SSRIand tricyclics)
Hormonal contraceptives
Tamoxifen
Antipsychotics
Corticosteroids
Herbs: ginseng,chasteberry,danshen
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
11
12. Systematic investigation
Determination of the clinical impact of
the symptom with HMB
Evaluation of the patient for the
underlying cause
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
12
13. Assesmeent of blood loss..
Frequency of changing "menstrual protection"
items, use of "double" protection;
changing menstrual protection at night; selfconsciousness about odor; inability to contain
"gushes" of menstrual
flow; embarrassment at being unable to contain
"gushes" of flow, and preparations and rituals to
prevent embarrassing episodes.
NICE Guideline 44; Heavy menstrual bleeding.
Women Health 2010;50(2): 195–211
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
13
14. Pelvic examination
pelvic signs are picked up with low
sensitivity and specificity in most situations,
especially when influenced by obesity and
the nervous patient.
postgraduate training improves the accuracy
of this examination,
Int J Gynaecol Obstet 2005;88(1):84–88
it is of great value in the evaluation of the
cervix.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
14
15. Labortatory assesment
Evaluation for coagulopathies that may
contribute to HMB (AUB-C) is important
in any setting
Ann Hematol 2005;84(5):339–342
Fertil Steril 2005;84(5):1345–1351
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
15
16. Acquire knowledge and clinical
skills to Comprehensively
evaluate the uterus
1. assessment of the endometrium for the
presence of hyperplasia or malignancy;
2.visualization of the endometrial cavity and cervical
canal for localized Lesions and
3.evaluation of the structure of the uterine wall for
adenomyosis, leiomyomas, and,
more rarely, arteriovenous malformations.
Semin Reprod Med 2011;29(5):391–399
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
16
17. Ultrasound
TVUS is undoubtedly the primary imaging
modality
highly dependent on the skill and
experience of the ultrasound operator
and contemporary machine !!!
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
17
18. TVUS
…an excellent tool for the
determination of whether further
investigation with curettage or some
form of endometrial biopsy is
necessary
Am J Obstet Gynecol. 2003 Feb;188(2):401-8.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
18
19. Typically, endometrial thickness is actually
measured and reported as the sum of the
two adjacent layers of endometrium, in
essence a double thickness,
a measurement called
the Endometrial Echo Complex, or EEC.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
19
20. as long as the EEC thickness is ≤12 mm
(in premenopausal women), there is a
very low incidence of
endometrial hyperplasia or neoplasia.
Ultrasound Obstet Gynecol 1998;11(5):337–342
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
20
21. Who should undergo
endometrial sampling?
AUB and an EEC >12 mm should be sampled.
age >45 years;
obesity (>90 kg)
a history of chronic anovulation,
infertility, or diabetes;
a family history of endometrial cancer; and
prolonged exposure to unopposed estrogens or
tamoxifen.
Am J Obstet Gynecol 1999;181(3):525–529
Colorectal cancer affected families with AUB
regardless of age
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
21
22. Endometrial sampling
Histological assessment of the
endometrium requires a biopsy or
curettage to evaluate for endometrial
hyperplasia or malignancy (AUB-M).
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
22
23.
Office endometrial sampling has a
reasonably high accuracy and detects 67
to 96% of endometrial carcinomas.
J Reprod Med 1995;40(8):553–555
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
23
24.
insufficient tissue obtained for diagnosis
has been reported in 4 to 20% of cases.
Gynecol Obstet Invest 1994;37(4):260–262
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
24
25. D and C left to Oblivion ???
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
25
26. Récamier's operation ( D &C )
named after French gynecologist who
designed curette.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
26
28. Dilatation and curettage alone should not be
used as a diagnostic tool.
suggested that D&C does not give additional diagnostic
information over and above a hysteroscopy with
endometrial biopsy and it is not therapeutic in cases of
heavy menstrual bleeding
NICE clinical guideline 44
11/14/2013
Heavy menstrual bleeding
Prof.Veerendrakumar,VIMS, Bellary.
28
29.
D&C should no longer be used as
the first-line method of investigating
PMB in most cases.
Scottish Intercollegiate Guidelines 2011
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
29
30.
it is limited in its ability to access the tubal
cornua of the uterus.
Hysteroscopy with biopsy provides more
information than dilatation and curettage
alone and rivals the combination of salineinfusion sonohysterography and endometrial
biopsy in its ability to diagnose polyps,
submucous fibroids, and other sources of
abnormal uterine bleeding.
Am Fam Physician. 2004 Apr 15;69(8):1915-1926.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
30
31.
Hysteroscopy with directed biopsy is
more sensitive in disclosing all types of
uterine lesions than dilatation and
curettage.
Curettage done after hysteroscopy and
directed biopsy does not improve the
detection of endometrial cancer
Eur J Gynaecol Oncol. 2007;28(5):400-2.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
31
32.
We support hysteroscopy as a
routine alternative to dilatation and
curettage in the diagnosis of
postmenopausal bleeding
J Obstet Gynaecol. 2001 Jan;21(1):67-9
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
32
34. D&C missed 58% (25/43) of polyps,
50% (5/10) of hyperplasias,
60% (3/5) of complex atypical Hyperplasias, and
11% (2/19) of endometrial cancers.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
34
35.
The limitations of D&C are due to the
blindness of the sampling procedure.
George Vorgias,etal 10/14/2003; Medscape General Medicine. 003;5(4)
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
35
36.
dilatation a
YOU SHOULD NOT BE OFFERED…
oral progestogens for use only in the second
half of your menstrual cycle
drugs called danazol and etamsylate
D and C, which involves scraping out the womb
lining – as a treatment or test on its own
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
36
38. Both EB and D& C
ineffective at diagnosing focal lesions.
Polyps (AUB-P) are frequently missed (up
to 50%) by blind techniques, which may
include cases of focal atypical hyperplasia
and carcinoma especially in
premenopausal cases.
Cancer 2000;89(8):1765–1772
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
38
43. SIS
Performed during proliferative phase
Not later than 10 days
Post menopuasal bleeding – any time
Women on HRT time it during withdrawal
or during progesterone phase
Bleeding not a contraindication but clot can
make interpretation difficult. But doppler can
differentiate cavitory lesions.
‘standard for the performance of saline
infusion sonohysterography. J Ultrasound
Med 2003
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
43
44. SIS
If a focal lesion is identified on SIS, that
lesion can be treated with hysteroscopy.
Those patients who do not have a focal
lesion can be spared hysteroscopy in
many cases.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
44
45. meta-analysis of 5892 women.
Using a double-wall thickness of 5 mm,the
sensitivity for detecting endometrial
cancer was 96%
A thin endometrium of 5 mm or less
had a high negative predictive value, and
this finding would support the diagnosis
of atrophy
JAMA 1998; 280:1510–1517.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
45
46. Pipelle curette is “excellent for detecting
endometrial processes when the
pathology is global in nature.”
When a focal lesion is detected a visually
directed biopsy is indicated.
J Reprod Med 1995; 40:553–555.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
46
47.
In postmenopausal women, polyps are
found to be the cause of bleeding in
approximately 30% of cases.
Most of these polyps are benign.
malignancy in polyps ranges from 0.5% to
1.5%.
Eur J Gynaecol Oncol 2000; 21:180–183.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
47
48.
Transvaginal sonography cannot
distinguish endometrial hyperplasia from
benign polyps
both conditions can cause thickening of
the endometrium, are hyperechoic, and
can contain cystic spaces.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
48
49. Saline infusion
sonohysterography
can distinguish focal lesions from diffuse
endometrial thickening. Polyps are focal
lesions, which project into the lumen of
the endometrial cavity
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
49
53. Sub mucous fibroid & polyp
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
53
54. Blood clot in the cavity
After dislodging with the catheter
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
54
55.
If the fibroid projects into the lumen
by more than 50% of its surface, then it
can be resected by hysteroscopy, obviating
an abdominal surgical procedure
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
55
57. SIS for monitoring the pts on
Tamoxifen
the finding of a normal endometrium on
SIS allowed these patients to avoid
further intervention.
Am J Roentgenol 1997; 168:657–661.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
57
58. Future direction
Endometrial biopsy with real time usg
guidance
Dubinsky AJR Am J Roentgenol 2000
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
58
59. SIS
Saline infusion sonohysterography is a
simple technique that yields additional
information over TVS in evaluation of
endometrial and subendometrial
conditions.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
59
60. Clinical impact
SIS added certainty to the
diagnosis in 88% of the patients studied.
SIS results changed the patients’
treatment in 80% of cases.
increased diagnostic confidence by 86%.
Radiology 2000; 216:260–264.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
60
61. hysteroscopy
In the presence of an abnormally thick
endometrium, when myomas exist
suspiciously close to the EEC or when
abnormal bleeding occurs or persists
despite a normal TVUS, hysteroscopy is
indicated.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
61
62.
Endometrial carcinoma and endometrial
hyperplasia (AUB-M), especially those
arising as a field defect, may not always be
clearly recognizable by hysteroscope
alone, which should be performed in
conjunction with endometrial biopsy.
Am J Obstet Gynecol 2007;196(3):243; e1-e5
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
62
63. SIS v/s Hysteroscopy
SIS is comparable to hysteroscopy in its
sensitivity for the diagnosis of
intracavitary polyps and submucosal
myomas
In SIS- limited evaluation of the
endocervical canal and the inability to
concurrently remove selected lesions
Fertil Steril 2010;94(7):2720–2725
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
63
64. One stop clinic..
Office hysteroscopy may be more cumbersome,
involves a steeper learning curve than either
TVUS or SIS, and may also be more
uncomfortable for the patient.
likely to achieve a primary diagnostic role if
narrow, rigid, or flexible scopes are used without
anesthesia or only with local cervical anesthesia
and with low-pressure saline distension in an
"office" situation
Clinical practice guidelines..Eur J Obstet Gynecol
Reprod Biol 2010;
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
64
65. Low resource settings..
When TVUS (including SIS) and
hysteroscopy are available, it is
recommended they be used in
complementary fashion.
In this way, hysteroscopy can be used
more selectively to exploit its use as a
therapeutic tool for the performance of
targeted biopsy, polypectomy, or
myomectomy.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
65
70. Myometrial evaluation
TVUS is generally useful for the
evaluation of myomas, 3 D may give
additional information.
TVUS is quite sensitive for the diagnosis
of diffuse adenomyosis.
Color flow Doppler is of value for the
detection of
arteriovenous malformations ,vascular
hyperplasias and malignancies. And focal
adenomyosis.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
70
71. Therapy
Once malignancy and significant pelvic
pathology have been ruled out, medical
treatment is an effective first-line
therapeutic option for abnormal uterine
bleeding.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
71
72. NSAID
reduced menstrual blood loss by 33% to
55% when compared with placebo,
without a significant difference in adverse
effects.
added benefit of improving
dysmenorrhea for up to 70% of patients.
START before the day of menses and
continue for 3-5 days.
Cochrane Database Syst Rev 2007;
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
72
73. Tranexemic acid
overall reduction in menstrual blood loss
between 40% and 59% from baseline.
1 gram of tranexamic acid taken orally
every 6 hours during menstruation, but a
single daily dose of 4 grams has also been
found to be effective
Intravenous tranexamic acid is available
for more acute scenarios, with a dose of
10 mg/kg every 6 hours.
Cochrane Database Syst Rev 2000;4:CD000249.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
73
74.
superiority of tranexamic acid to lutealphase progestins and NSAID
BMJ 1996;313:579–82
No statistically significant increase in VTE
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
74
75. Hormonal..
cyclic luteal-phase progestin therapy is
significantly less effective in treating
“menorrhagia” than NSAIDS, tranexamic acid, or
danazol
In contrast, long-cycle, high-dose oral progestins
have been shown to reduce menstrual losses for
women with heavy menstrual bleeding.
There are no published trials investigating the
impact of DMPA on abnormal uterine bleeding
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
75
76.
Woman has never learned to live
healthy & happy without
progesterone coverage of estrogen
primed state
Its not simply a Pregnancy Hormone.
But in true sense,
‘A Mother Hormone.’
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
76
77. LNG-IUS
Maximal Benefits Outweigh Minimal
Risks.
A reduction in menstrual blood loss of
86% at 3 months and 97% at 12 months
was demonstrated in a single-arm study
on the use of the LNG-IUS in women
with menorrhagia,
20-80% become amenorrhic by 12
months.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
77
78.
Hurskainen et al. randomized women with
menorrhagia to receive either a hysterectomy or
insertion of the LNG-IUS. The two groups had
similar health-related quality of life scores at 5
years.
JAMA 2004;291:1456–63.
women awaiting hysterectomy,
Over two thirds of the women who had the LNGIUS inserted cancelled their surgery versus just
14.3% in the control group.
BMJ 1998
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
78
79.
Danazol and gonadotropin-releasing
hormone agonists will effectively reduce
menstrual bleeding, and may be used for
scenarios in which other medical or
surgical treatments have failed or are
contraindicated. (I-C).
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
79
80. SERM’s – The Designer Estrogens
SERMs are designed to
act in a specific ways at
each of the receptor sites
J Clin Oncol 2000 18:3172-3186.
Estrogens
SERMs
Tomoxifine
Droloxifine
Toremifine
Raloxifine
Ormeloxifine
Antiestrogens
J Clin Oncol 2000 18:3172-3186.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
80
81. Ideal SERM for DUB
No uterine stimulation
Prevents bone loss
Has no risk for breast cancer
Has a positive effect on lipids &
cardiovascular system
Maintains cognitive function of the brain
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
81
83. Weekly twice for 12 weeks
weekly once for 12 weeks
74 of 85 subjects (87%) showed a reduction in
endometrial thickness
Only 8.2% of women needed hysterectomy
J Obstet Gynecol Ind vol. 54, No 1 2004
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
83
84.
Amenorrhea with the therapy – 18 patients
(42.9%)
ovarian cyst (7.1%), cervical erosion and
discharge (7.1%), gastric dyspepsia (4.8%),
vague abdominal pain (4.8%) and headache
(4.8%)
J. Obstet. Gynaecol. Res. 2009
Ormeloxifene is more effective as compared to MPA in
reducing the blood loss in the treatment of DUB.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
84
85. Surgical management
indications-failure to respond to medical therapy,
-inability to utilize medical therapies (i.e.
side effects, contraindications),
-significant anemia,
-impact on quality of life, and
-concomitant uterine pathology (large
uterine fibroids, endometrial hyperplasia).
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
85
86. 2nd generation techniques
recommended
Several non-hysteroscopic ablation
techniques are currently available.
Balloon, microwave, and radiofrequency
ablation devices have a large reported
clinical experience.
avoids the use of operating room resources
and general anaesthetic.
SOGC guidelines 2013
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
86
88. HYSTERECTOMY
THE most definitive treatment.
Consider the least invasive method.
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
88
89.
From Research to Practice –
Long Way to Go…..
Technology made large populations
possible and large populations today make
technology indispensible
11/14/2013
Prof.Veerendrakumar,VIMS, Bellary.
89